TCT-191 Intravenous β-blockers for Patients with ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Meta-analysis of Randomized Trials.

Abstract

RESULTS With survival analysis of 1-year clinical follow up, A stepwise increase of the composite of CD and MI was observed in the transition from SA to STEMI. (SA; 1.2% vs. UA; 1.4% vs. NSTEMI; 5.2% vs. STEMI; 8.1%; Log-Rank < 0.001). Even in the comparison of stabilized patients with MI up to 5-year follow up, there was the same pattern of transition (SA; 1.7% vs. UA; 2.0% vs. NSTEMI; 3.9% vs. STEMI; 4.3%; Log-Rank 1⁄4 0.002).

DOI: 10.1016/j.jacc.2016.09.333

Cite this paper

@article{Mahmoud2016TCT191I, title={TCT-191 Intravenous β-blockers for Patients with ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Meta-analysis of Randomized Trials.}, author={Ahmed N Mahmoud and Akram Y Elgendy and Hend Mansoor and Mohammad Khalid Mojadidi and Islam Y Elgendy and Anthony A Bavry}, journal={Journal of the American College of Cardiology}, year={2016}, volume={68 18S}, pages={B78} }